Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression [Phase 4]

View source ↗

Summary

A Phase 4 comparative effectiveness study examining two forms of ketamine for treatment-resistant depression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (form A) (Ketamine)
  • Ketamine (form B) (Ketamine)

Snippet

Sponsor: The George Institute | Conditions: Treatment Resistant Depression | Phase 4 | Status: RECRUITING